<div><p></p><p><b>Background.</b> Breast cancer is characterized by great molecular heterogeneity demonstrated, e.g. by the intrinsic subtypes. Administration of post-mastectomy radiotherapy (PMRT) does, however, not reflect this heterogeneity. A gene profile (DBCG-RT profile) has recently been developed and validated, and has shown prognostic impact in terms of loco-regional failure and predictive impact for PMRT. Reports have also shown predictive value in terms of benefit of PMRT from intrinsic subtypes and derived approximations. The aim of this study was to examine: 1) the agreement between various methods for determining the intrinsic subtypes; and 2) the relationship between the prognostic and predictive impact of the DBCG-RT profile...
JOURNAL ARTICLE;INTRODUCTION Recurrence risk in breast cancer varies throughout the follow-up time....
We and others have recently shown that tumor characteristics are altered throughout tumor progressio...
Background: Adjuvant radiotherapy is the standard of care after breast-conserving surgery for primar...
<p><b>Background:</b> The study of the intrinsic molecular subtypes of breast cancer has revealed di...
Systemic treatments are tailored to breast cancer (BC) heterogeneity, which is not yet taken into ac...
The study of the intrinsic molecular subtypes of breast cancer has revealed differences among them i...
We previously identified 34 genes of interest (GOI) in 2006 to aid the oncologists to determine whet...
BACKGROUND: The relative contribution of biologic subtype to locoregional recurrence (LRR) in patien...
AbstractWe previously identified 34 genes of interest (GOI) in 2006 to aid the oncologists to determ...
This study aims to explore gene expression profiles that are associated with locoregional (LR) recur...
Abstract Background Optimizing treatment through microarray-based molecular subtyping is a promising...
Background. Breast cancer is the highest prevalence of malignancy for women in Indonesia and importa...
Biological changes that occur during metastatic progression of breast cancer are still incompletely ...
The 70-gene signature (MammaPrint (TM)) has been developed to predict the risk of distant metastases...
Biological changes that occur during metastatic progression of breast cancer are still incompletely ...
JOURNAL ARTICLE;INTRODUCTION Recurrence risk in breast cancer varies throughout the follow-up time....
We and others have recently shown that tumor characteristics are altered throughout tumor progressio...
Background: Adjuvant radiotherapy is the standard of care after breast-conserving surgery for primar...
<p><b>Background:</b> The study of the intrinsic molecular subtypes of breast cancer has revealed di...
Systemic treatments are tailored to breast cancer (BC) heterogeneity, which is not yet taken into ac...
The study of the intrinsic molecular subtypes of breast cancer has revealed differences among them i...
We previously identified 34 genes of interest (GOI) in 2006 to aid the oncologists to determine whet...
BACKGROUND: The relative contribution of biologic subtype to locoregional recurrence (LRR) in patien...
AbstractWe previously identified 34 genes of interest (GOI) in 2006 to aid the oncologists to determ...
This study aims to explore gene expression profiles that are associated with locoregional (LR) recur...
Abstract Background Optimizing treatment through microarray-based molecular subtyping is a promising...
Background. Breast cancer is the highest prevalence of malignancy for women in Indonesia and importa...
Biological changes that occur during metastatic progression of breast cancer are still incompletely ...
The 70-gene signature (MammaPrint (TM)) has been developed to predict the risk of distant metastases...
Biological changes that occur during metastatic progression of breast cancer are still incompletely ...
JOURNAL ARTICLE;INTRODUCTION Recurrence risk in breast cancer varies throughout the follow-up time....
We and others have recently shown that tumor characteristics are altered throughout tumor progressio...
Background: Adjuvant radiotherapy is the standard of care after breast-conserving surgery for primar...